Financial Results

Key highlights

Filter

Period

Filter by

recent search

Reset

Showing: 1 – 05 of 23 Financial Results

Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
 –  26 October 2023

26 October 2023

Download
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, today presents its sales performance for the year to date and the third quarter of 2023.


Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
 –  27 July 2023

27 July 2023

Download
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance

The performance in the first half of the year is reflected in today’s upgrade to our full-year guidance. We look forward to more milestones and further expansion of the pipeline over time through additional external-innovation transactions. I am confident, as…


Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
 –  27 April 2023

27 April 2023

Download
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance

Paris (France), 27 April 2023


Ipsen presents strong full-year 2022 results and guidance for 2023
 –  09 February 2023

09 February 2023

Download
Ipsen presents strong full-year 2022 results and guidance for 2023

Paris (France), 9 February 2023


Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
 –  27 October 2022

27 October 2022

Download
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance

Paris (France), 27 October 2022


1 2 3 4 5

Your dedicated contacts